Articles

Percuntaneous Coronary Intervention PCI Cath Lab Stents Clinical Trial Study

Expanded use of percutaneous coronary intervention (PCI) is seeing more patients with acute coronary syndromes treated more quickly, according to the latest National ...

The Centers for Medicare and Medicaid Services (CMS) released findings on a number of its initiatives to reform the healthcare delivery system. These include interim financial results for select...

Cardiac Ultrasound Systems Point-of-Care Cardiology Clinical Study

A paper in the journal of the World Heart Federation, Global Heart, reported mounting evidence of the utility of ...

Sapien 3, TAVR, CE mark, european approval

Edwards Lifesciences Corp. received CE marking for its Edwards Sapien 3 transcatheter aortic valve.

FDA Premarket Approval PMA Clinical Study EP Lab Cath Leads Implantable Devices

The U.S. Food and Drug Administration (FDA) has approved many cardiac implantable electronic device...

Icahn Mount Sinai HDL LDL Nanotherapy Stem Cell Therapies Cath Lab

An international research team, led by Icahn School of Medicine at Mount Sinai investigators, designed and tested a high-density lipoprotein (HDL) nanoparticle loaded with a statin drug. In mouse...

Carotid Stent Clinical Study Abbott Cordis National Cardiovascular Data Registry

The three most common systems to place stents in blocked carotid arteries of the neck have similarly low rates of...

The Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics (TCT) 2013 offers many new insights about the latest cardiovascular technologies and treatment techniques. These...

Medtronic Corevalve, FDA

The U.S. Food and Drug Administration (FDA) granted U.S. market approval for Medtronic’s self-expanding transcatheter aortic...

Medtronic, corevalve, edwards, litigation, TAVR, TAVI

In a move that calls into question the future of transcatheter valve competition in the United States, a jury in the Federal District Court of Delaware decided Jan. 15 the Medtronic CoreValve...